To further investigate the diagnostic power of TARBP2, DICER, and DROSHA in adrenocortical tumors and overcome limitations of pathological assessment, we applied disease-free survival as the end point for diagnosing ACC, which is similar to the approach applied by de Reynies et al. (2009). The gene discussed is TARBP2; the disease is adrenal cortex carcinoma.